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Abstract
Toxic metals are not so rare but are often neglected causes 
of alopecia areata in men and women. Thallium, arsenic, se-
lenium, and mercury are the most common cause of metals-
related alopecia, which is what Vicky Yu and colleagues’ 
found. Other than the presence of thallium, arsenic, mercury, 
and selenium, cadmium, bismuth, lithium, and copper 
should also be taken into account when dermatologists are 
considering toxic metals as a potential cause of alopecia 
areata in humans. © 2020 S. Karger AG, Basel
To the Editor,
It was a pleasure to read the review article by Vicky Yu 
and colleagues [1] on the diagnosis of acquired alopecia 
associated with exposure to toxic metals in humans [1]. 
In their excellent review of the roles of chemical substanc-
es in the pathogenesis of alopecia, the investigators found 
that some toxic metals – thallium (Tl), arsenic (As), and 
mercury (Hg), including the trace element selenium 
(Se) – can cause alopecia in humans [1]. However, we 
think that clinicians should also consider other 4 metallic 
elements in patients with alopecia following acute and/or 
chronic exposure: cadmium (Cd), bismuth (Bi), copper 
(Cu), and lithium (Li) [2–4].
In 19 years of surveillance for metals-related diseases 
in Milan, Italy, a cluster of cases of alopecia areata has 
been identified in our cohort (25 of 1,376 patients) [5]. 
We would like to share our experience, for instance, in a 
cohort of patients with adverse events to dental toxic met-
als [5, 6].
We retrospectively studied 25 consecutive patients 
with alopecia areata who were seen at a single dental unit 
(17 of 25, 68%). The remaining patients (8 of 25, 32%) 
with confirmed disease were from our Department of 
Dermatology between 2000 and 2019 (unpublished data). 
Seven physician-researchers took part. Twenty-four pa-
tients (90%) had alopecia areata. Of the 25 patients, only 
one had cicatricial (scarring) alopecia (Table 1).
As estimated from previous studies [7–9], the preva-
lence of alopecia areata worldwide is between 0.57 and 
3.8% [9]. Here, we report the prevalence rate for alopecia 
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areata – in our cohort of patients with adverse health ef-
fects to dental toxic metals – which is 1.74% (24 of 1,376) 
(Table 1). Our prevalence results are similar to that re-
ported in the worldwide literature [9], which has shown 
that the rates for alopecia areata cases vary widely from 
0.57 to 3.8% [8, 9].
Our metal-exposed patients were then confirmed with 
the use of highly specific laboratory tests (toxicological 
assessment) [5, 6]. This observation has been established 
by a recent immunotoxicology textbook [5].
We noted an association between low serum zinc lev-
els and alopecia areata induced by toxic metals [5]. This 
finding supports the suggestion that such zinc homeosta-
sis imbalance is the underlying pathophysiologic mecha-
nism for the development of alopecia areata. In our view, 
zinc depletion has an important role in the development 
of alopecia areata [10–15]. Therefore, alopecia areata can 
be attributed to an underlying, long-undiagnosed, zinc 
deficiency state [16, 17]. Zinc deficiency in humans was 
first described by US researchers in the 1970s under the 
name “conditioned deficiency of zinc” [17]. Dermatolog-
ically, the level of zinc was low in plasma/serum and some 
tissues in newborn infants as well as in children with zinc 
deficiency who had partial or total hair loss, and derma-
titis [12, 14, 16, 17].
Although specific markers of zinc deficiency have not 
been reported [15–17], we summarized the literature in 
Table 2. In our experience, biomarkers from blood sam-
ples – particularly when lowered initially – may be useful 
Table 1. Sex-specific prevalence of alopecia areata and any alopecia related to toxic metal exposure




% men – 
prevalence
% total – 
prevalence
% women – 
prevalence
% menb – 
prevalence
% total – 
prevalence
% %
17 of 24 70.83 7 of 24 29.17 24 of 1,376 1.74 17 of 1,376 1.27 8 of 1,376 0.58 25 of 1,376 1.82 0.57–3.8
Twenty-five case subjects were determined using 1,376 individuals with adverse events to nonessential metal toxicants. The table shows baseline char-
acteristics of the pilot study cohort. The mean age of the study cohort was 48.9 years (range, 22–74 years) and the cohort contained 17 women (68%) and 8 
men (32%). a Only 1 patient had combined overexposure to mercury (Hg) and aluminum (Al). This patient, a woman, had been diagnosed with alopecia 
universalis at 37 years of age. b One isolated case, a 43-year-old man, categorized clinically as definitely not having alopecia areata, but cicatricial alopecia 
(scarring alopecia) associated with chronic overexposure to mercury and arsenic was not included in the alopecia areata group.
Zinc biomarkers
n zinc biomarker 
(marker name)
full name medium referent level
1 ALP Alkaline phosphatase Serum Low/decreased
2 LDH Lactate dehydrogenase Serum Low/decreased
3 AGP Alpha-1-glycoprotein Serum Low/decreased
4 A2M Alpha-2-macroglobulin Serum Low/decreased
5 ALB Albumin Serum Low/decreased
6 TTR Transthyretin (prealbumin) Serum Low/decreased
Table 2. Indications for biochemical 
studies that should be tailored to the 
individual patient, according to the degree 
of zinc deficiency (below the reference 
range; zinc plasma/serum <80 μg per dL)
Table 3. Acute and/or chronic exposure to potentially toxic metals 
as the cause of alopecia areata
Toxic metals associated to alopecia areata
n metallic elements chemical symbol references
1 Aluminum Al This report
2 Arsenic As [1, 2]
3 Bismuth Bi [4]
4 Cadmium Cd [4]
5 Copper Cu [2]
6 Lithium Li [3]
7 Mercury Hg [2, 5, 19]
8 Selenium Se [1]
9 Thallium Tl [1, 22]
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for clinical prediction of outcomes (Table 2). There is a 
risk of primary or secondary malabsorption states, both 
treatable with zinc repletion (mainly zinc sulfate, ZnSO4), 
that should be considered [15–17].
About mercury, it is important to remember that all 
forms of mercury compounds (elemental, inorganic, and 
organic) are able to induce alopecia areata [5, 18, 19]. This 
may explain why, in the past, there have been cases of 
alopecia in patients who have been taking intravenous 
immune globulin injections, containing thimerosal [20].
Our recent reports suggest that mechanisms underly-
ing these hair falls involve acute and/or chronic exposure 
to toxic metals [5], especially mercury, which could have 
a varied and widespread influence on the growth of hair 
(scalp hair), throughout the skin apparatus.
Toxic metals inactivate proteins and may block sulfhy-
dryl cross-linking in keratin (disulfide-linked keratin, Ta-
ble 3), causing hair loss. Essentially, zinc is replaced by 
toxic metals through molecular mimicry, substitution, 
and competition for metabolism in the biological system 
[5, 17, 21].
Dermatologists should be aware that patients with alo-
pecia should be carefully monitored for acute and/or 
chronic exposure to potentially toxic metals.
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